Adverse events can affect more than just humans 🐾
Explore the world of veterinary #pharmacovigilance this #VetMedSafetyDay. Listen to our two-part #DrugSafetyMatters episode featuring James Mount to learn more:
Part 1 🎧 https://ow.ly/ypfz50UFlG8
Part 2 🎧 https://ow.ly/9GlB50UVHqC
🎧 Michele Fusaroli and Eugene van Puijenbroek join us on the #DrugSafetyMatters podcast to discuss the common pitfalls of disproportionality, how to avoid them, and why guidelines and a cultural shift are needed to prevent misuse.
Listen in today 👉 https://ow.ly/Q0FA50YCMkS
#pharmacovigilance
Stay informed about all things #pharmacovigilance by listening to our podcast #DrugSafetyMatters. Some of our latest episodes cover:
🩻 Medical devices
🌐 The WHO Global Smart PV Strategy
🤖 Artificial intelligence in PV
🎧 Listen now at 👉 https://www.drugsafetymatterspod.org
#AI #MedicalDevices
🎧 We're celebrating 50 000 downloads of the #DrugSafetyMatters podcast! 🎉
Thank you to our avid followers for tuning in and to our guest speakers for sharing their unique perspectives on topical issues in #pharmacovigilance.
Listen to all episodes 👉 https://www.drugsafetymatterspod.org/
Cross-functional collaboration among professionals in quality assurance, engineering, and drug safety is needed to ensure the safety of medical devices.
🎧 We chat #MedicalDevice safety with Omar Aimer, President of ISoP, in part 2 of this #DrugSafetyMatters episode 👉 https://ow.ly/y9WQ50Yp7sI
From bandages to pacemakers, medical devices play a vital role in modern healthcare and in the daily lives of patients.
In this two-part episode of #DrugSafetyMatters, Omar Aimer, breaks down medical device vigilance.
Listen up 🎧 ow.ly/M36I50Y8JKZ
#pharmacovigilance #MedicalDevices
🎧 Catch up on recent #DrugSafetyMatters episodes and stay informed about some of the most pressing issues in the world of medicines safety. Our latest episodes explore:
🌐 The WHO Global Smart PV Strategy
🤖 #AI in pharmacovigilance
👧🏻 Paediatric PV
Tune in 👉 https://www.drugsafetymatterspod.org
It's time to reveal the number 1️⃣ #DrugSafetyMatters episode of 2025! 🎧
Our listeners were keen to hear how versatile generative #AI models are raising the bar for what's possible in #pharmacovigilance, and what's needed to regulate their use.
Niklas Norén tells us more 👉 ow.ly/iRPq50Xq0xP
Coming in at number 2️⃣ on our #DrugSafetyMatters countdown for 2025 is Episode 36.
Levente Pápai, Lovisa Sandberg, and Sara Vidlin discuss the complexities and challenges of pregnancy-related #pharmacovigilance and the VigiBase pregnancy algorithm.
Listen now 🎧 ow.ly/bT8250VrmAK
🔄 We continue our countdown of the #DrugSafetyMatters top 5 episodes of 2025.
In the ️4th spot, Henry Zakumumpa discusses data quality in ADR reports and what regulators and #pharmacovigilance centres can do to improve it.
Tune in 🎧 https://ow.ly/PPiY50W6S6b
As 2025 comes to a close, we're counting down the top 5 #DrugSafetyMatters episodes of the past year.
At number 5️⃣, we explore veterinary #pharmacovigilance with James Mount.
🎧 Listen to the episode for more 👉 ow.ly/9GlB50UVHqC
What are the 4️⃣ pillars of the WHO Global Smart #Pharmacovigilance Strategy, and how will it help foster strong, adaptive, and trusted regulatory systems globally?
Shanthi Pal unpacks the strategy in the latest episode of #DrugSafetyMatters.
🎧 Tune in 👉 ow.ly/Yrug50XLpiE
#PatientSafety #MedSky
We continue our discussion on the use of #AI in #pharmacovigilance on the #DrugSafetyMatters podcast.
Niklas Norén tells us how to keep pace with rapid technological developments while ensuring that sensitive patient data remains protected.
🎧 Tune in 👉 ow.ly/tibY50XAuCc
In this two-part episode of #DrugSafetyMatters, we're joined by Niklas Norén to discuss how #AI can add value to #pharmacovigilance and how a risk-based approach to its regulation can help maintain human oversight throughout the PV cycle.
🎧 Tune in to Part 1 to learn more 👉 ow.ly/iRPq50Xq0xP
Medication-related harm is especially prevalent in older adults due to changing physiology, increased frailty, and incidence of #polypharmacy.
Giovanni Furlan discusses #pharmacovigilance in older adults on the #DrugSafetyMatters podcast.
Listen now 🎧 ow.ly/vEeV50U67GU
#OlderPersonsDay
👦🏾👧🏻 Ahead of #WPSD2025 on 17 September, we spoke with
Angela Caro-Rojas to discuss the challenges and solutions in paediatric #pharmacovigilance and how we can put children first when it comes to #PatientSafety.
🎧 Listen to #DrugSafetyMatters for more 👉 ow.ly/8Gfp50WPCSl
Why is the world still behind when it comes to pregnancy #pharmacovigilance?
Sara Vidlin, Levente Papai, and Lovisa Sandberg join the #DrugSafetyMatters podcast to discuss the challenges and new solutions that can help address the complexities of #pregnancy PV.
🎧 Tune in 👉 ow.ly/bT8250VrmAK
Stay informed about all things #pharmacovigilance by listening to our podcast #DrugSafetyMatters. Some of our latest episodes cover:
🗣️ Patient perspectives in PV
📝 Quality in ADR reporting
🫄 Pregnancy-related pharmacovigilance
🎧 Listen now at 👉 www.drugsafetymatterspod.org
#Pharmacovigilance will need to engage patients in diverse ways to ensure future safety.
🎧 Listen to Angela Caro Rojas and panellists discuss patient perspectives in PV in this special episode of #DrugSafetyMatters, recorded at the ISoP Mid-Year Symposium #ISoPUppsala2025 👉 ow.ly/lRhN50WgWhy
Spontaneous adverse event reports are a cornerstone of #pharmacovigilance. Yet underreporting and data quality issues still plague PV systems globally. How can we improve?
🎧 Tune in to #DrugSafetyMatters to hear more about data quality in ADR reports 👉 ow.ly/PPiY50W6S6b
#podcast #PatientSafety
A graphic advertising a forth coming podcast episode, with photos and text identifying the guests. There is a magnifying glass hovering over an AI robot with the letters 'PV' over its hand.
What are the risks of not regulating how we use #AI tools in #pharmacovigilance?
Niklas Norén will answer this question and more on the #DrugSafetyMatters podcast.
💬 Here's your chance to #AskUsAnything – comment with your questions below👇 by 8 June!
Why is the world still behind when it comes to pregnancy #pharmacovigilance?
In a new #DrugSafetyMatters, we're joined by UMC researchers to discuss the challenges and new solutions that can help address the complexities of pregnancy PV.
🎧 Listen up 👉 ow.ly/bT8250VrmAK
🎧 Levente Pápai, Lovisa Sandberg, and Sara Vidlin discuss pregnancy pharmacovigilance and the new VigiBase pregnancy algorithm in this episode of #DrugSafetyMatters
👉 ow.ly/bT8250VrmAK
Did you know that we have a #podcast?
#DrugSafetyMatters brings intriguing and inspiring stories from the world of #pharmacovigilance right to your ears. Some of our latest episodes cover:
🫄 Pregnancy PV
🐾 Veterinary PV
📝 Narrative fields
🎧 Tune in 👉 www.drugsafetymatterspod.org
Bonne année 2025 à tous ! 🎉
En cadeau mon podcast sur les cygnes noirs en Pharmacovigilance
Cet épisode de #DrugSafetyMatters est le podcast numéro 1 en 2024 !
Rejoignez la chasse aux cygnes noirs dans le monde de la pharmacovigilance
C’est ici 👉 ow.ly/orLo50QJVt3
